Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Amylin Selects Ohio as Site for Expansion of Production Plant

  • Amylin is increasing construction at the manufacturing facility in West Chester, OH, to increase investment to a total of approximately $400 million.

    The company is expanding its existing production plant near the Union Center Boulevard district, which is now in the process of being equipped to manufacture it long-acting release (LAR) formulation of exenatide, a compound in development for type 2 diabetes.

  • You’re all set! Thank you for subscribing to GEN Highlights.